Interactive Virtual Presentation
Future Generations: Understanding the Similarities and Differences Among Direct-Acting Antivirals for Hepatitis C
Source: Future Generations: Understanding the Similarities and Differences Among Direct-Acting Antivirals for Hepatitis C
Future Generations: Understanding the Similarities and Differences Among Direct-Acting Antivirals for Hepatitis C
|
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify the various classes and targets for direct-acting antiviral agents (DAAs) for hepatitis C
- Contrast the features of investigational DAAs, including activity profiles, resistance, and adverse effects
- Compare the characteristics of regimens that incorporate investigational DAAs, including duration of treatment, response-guided approaches, and the continuing role of currently approved therapies
- Critically appraise potential future directions in the use of DAAs, including considerations that may affect their coadministration with other DAA agents
Topics covered include:
- Classes and targets for direct-acting antiviral agents (DAAs) for hepatitis C
- Features of investigational DAAs, including activity profiles, resistance, and adverse effects
- Characteristics of regimens that incorporate investigational DAAs, including duration of treatment, response-guided approaches, and the continuing role of currently approved therapies
- Potential future directions in the use of DAAs, including considerations that may affect their coadministration with other DAA agents
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|